πŸ‡ΊπŸ‡Έ FDA
Patent

US 12383512

Cannabidiol-type cannabinoid compound

granted A61KA61K31/05A61K36/185

Quick answer

US patent 12383512 (Cannabidiol-type cannabinoid compound) held by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/05, A61K36/185, A61P, A61P25/08